Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.
暂无分享,去创建一个
[1] R. Zotz,et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. , 2000, The New England journal of medicine.
[2] M. Prins,et al. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. , 1999, Blood.
[3] I. Greer,et al. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy , 1999, British journal of obstetrics and gynaecology.
[4] M Gent,et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. , 1999, The New England journal of medicine.
[5] P. Prandoni,et al. Low Rate of Venous Thromboembolism in Asymptomatic Relatives of Probands with Factor V Leiden Mutation , 1999 .
[6] M. Prins,et al. Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia , 1999, Thrombosis and Haemostasis.
[7] P. Chiusolo,et al. Additional genetic risk factors for venous thromboembolismin carriers of the factor V Leiden mutation , 1998, British journal of haematology.
[8] P. Simioni,et al. Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant , 1998, British journal of haematology.
[9] P. Mannucci,et al. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. , 1997, Circulation.
[10] M. Prins,et al. The Incidence of Venous Thromboembolism in Family Members of Patients with Factor V Leiden Mutation and Venous Thrombosis , 1998, Annals of Internal Medicine.
[11] M. Makris,et al. Co-inheritance of the 20210A Allele of the Prothrombin Gene Increases the Risk of Thrombosis in Subjects with Familial Thrombophilia , 1997, Thrombosis and Haemostasis.
[12] P. Ridker,et al. Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical Perspective , 1997, Annals of Internal Medicine.
[13] L. Welin,et al. Deep vein thrombosis and pulmonary embolism in the general population. 'The Study of Men Born in 1913'. , 1997, Archives of internal medicine.
[14] O. Linder,et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. , 1997, The New England journal of medicine.
[15] M. Prins,et al. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden). , 1997, The New England journal of medicine.
[16] P. Prandoni,et al. Hyperhomocysteinemia and deep-vein thrombosis. A case-control study. , 1996, Thrombosis and haemostasis.
[17] F R Rosendaal,et al. Factor V Leiden: should we screen oral contraceptive users and pregnant women? , 1996, BMJ.
[18] P. Simioni,et al. Homozygous patients with APC resistance may remain paucisymptomatic or asymptomatic during oral contraception. , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[19] Vittorio Pengo,et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.
[20] A. Cogo,et al. Prevalence of Antiphospholipid Antibodies and Lupus Anticoagulant in Juvenile Patients with Objectively Documented Deep-vein Thrombosis , 1996 .
[21] P. Ridker,et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.
[22] P. Reitsma,et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) , 1995, Blood.
[23] P. Prandoni,et al. Noninvasive objective tests for the diagnosis of clinically suspected deep-vein thrombosis. , 1995, Haemostasis.
[24] P. Reitsma,et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation , 1994, The Lancet.
[25] B. Dahlbäck,et al. Resistance to activated protein C as a basis for venous thrombosis. , 1994, The New England journal of medicine.
[26] P. Reitsma,et al. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. , 1994, Blood.
[27] F. Rosendaal,et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study , 1993, The Lancet.
[28] B. Lindblad,et al. A prospective study of the incidence of deep‐vein thrombosis within a defined urban population , 1992, Journal of internal medicine.
[29] Burke,et al. Diagnosis of Pulmonary Embolism D IAGNOSTIC R EASONING , 2007 .